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Natural killer (NK) cells are lymphocytes of the innate immune system that are able to 
secrete cytokines and detect virus infected and transformed cells. Contrary to T cells, 
NK cells recognize targets that lack expression of MHC class I molecules at the cell 
surface, a phenomenon referred to as “missing self” recognition. The process is 
dependent on a NK cell receptor family termed killer-cell immunoglobulin-like 
receptors (KIRs) and their interaction with MHC class I. However, although we have 
gained insights into the molecular specificity of NK cell responses, several fundamental 
questions relating to the generation of human NK cell repertoires remain elusive. Some 
studies imply that there is a minor effect of HLA on KIR expression frequencies, but it 
is unclear to what extent this leads to a bias for expression of self-KIRs in the total 
repertoire. In this thesis we sought to investigate how inhibitory KIR repertoires are 
formed and whether selection is required to preserve self tolerance and maximize the 
ability of NK cells to detect abnormal expression of MHC class I. 
 
Here, we have used a unique platform for multi-parameter flow cytometry and 
performed a detailed evaluation of complete inhibitory KIR repertoires in healthy 
donors. We compared observed experimental data with theoretical data obtained under 
random sequential KIR acquisition in the presence and absence of selection. We found 
that co-expression of multiple KIRs was more frequent than expected by the product 
rule and that the probability of KIR acquisition increased with cellular expression of 
other KIRs. Presence or absence of self MHC class I molecules did not influence the 
total KIR repertoire, neither with respect to the number of receptors expressed nor the 
type (self versus non-self) of KIR. In parallel with the acquisition of KIRs we also 
noticed a gradual downregulation of NKG2A and appearance of CD57. Hence, we 
propose that the expression patterns of the receptors define different stages in a 
differentiation process of the CD56dim NK cell population. Our data provide new 
insights into the formation of human KIR repertoires and revisit prevailing models of 
NK cell selection. 
 
The combination of KIR and HLA genes influence outcomes of human diseases and 
treatment thereof. In hematopoietic stem cell transplantation (HSCT), it is sometimes 
necessary to search for unrelated partially HLA-mismatched donors. In such situations, 
a potential beneficial role for NK cell alloreactivity may occur based on missing KIR 
ligands in the recipient. Prediction of NK cell alloreactivity in allogeneic HSCT is 
currently determined by HLA and KIR genotyping. However in this thesis we 
demonstrate that although a particular donor is mismatched to the recipient on a genetic 
level, the frequency of alloreactive NK cells may range from 0 to 62%. The results 
demonstrate a vast variability of the functional and alloreactive NK cell repertoire and 
have implications for donor selection in HSCT and adoptive NK cell-based 
immunotherapy. 
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1 INTRODUCTION 
During daily life, we are constantly exposed to microorganisms in our surroundings, 
yet we are rarely ill. The body is protected against foreign pathogens by a variety of 
effector cells and molecules that together make up the immune system. Throughout the 
years, the immune system has evolved and developed an ability to distinguish self from 
nonself as foreign pathogens seek new ways to avoid detection. The knowledge we 
have today about the immune system is too vast to be covered in this thesis. Instead, the 
introduction is focused on a type of white blood cell known as the natural killer (NK) 
cell [1, 2]. 
 
 
1.1 NK CELL BIOLOGY 
NK cells were first described in 1975 by two independent groups, by Kiessling et al., at 
the Karolinska Institute and Herberman et al., at National Institutes of Health [3-6]. 
Several groups had observed a mysterious background killing against tumor cells by 
unimmunized lymphocyte populations that could not be explained by T cell 
cytotoxicity [7, 8]. However, the two groups identified a new cell population 
responsible for the phenomenon. The newly found large granular lymphocytes were 
named natural killer cells because of their ability to lyse target cells without prior 
sensitization. 
 
In 1981, Klas Kärre speculated in his thesis around the still unsolved area of NK cell 
specificity. He reflected on the fact that T- and NK cell target recognition seemed to 
complement each other, that F1 hybrids rejected parental cells and the NK cell 
mediated rejection of allogeneic lymphomas [9-11]. From this he proposed the 
“missing self” hypothesis, which was based on the idea that target cells that fail to 
express self MHC class I molecules were sensitive to NK cell killing [12]. The idea 
was later experimentally supported when lymphoma cells, with lower MHC levels than 
wildtype, were rejected after inoculation in syngeneic mice [13]. The “missing self” 
hypothesis predicted that NK cells must possess inhibitory receptors that are able to 
sense the loss of self MHC class I molecules. In the beginning of the 90ies this 
assumption was confirmed by the discovery of the MHC class I binding receptors, the 
killer-cell lectin-like receptors (Ly49) in mice and the killer-cell immunoglobulin-like 
receptors (KIRs) in humans [14-16]. Hence, a molecular explanation of “missing self” 
recognition was provided, and the model has since then been the basis for many new 
concepts regarding NK cell responses.  
 
Today, an array of inhibitory and activating receptors has been discovered and it has 
been established that a balance of both activating and inhibitory signals regulates NK 
cell responses [17, 18]. Activating signals can be provided by cytokine release during 
viral infection, where NK cells are stimulated by interleukin (IL)-2, IL-12, IL-15 and 
IL-18 [19-21]. Other ways of activation could be achieved by stimulation through 
FCγRIII (also known as CD16), a receptor recognizing the Fc portion of antibodies. 
Engagement of CD16 allow NK cells to actively lyse IgG coated cells in a process 
called antibody-dependent cellular cytotoxicity (ADCC) [22, 23]. Additionally, the 
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natural cytotoxicity receptors (NCR) NKp30, NKp44 and NKp46 are important 
mediators of activation [24-27]. Despite the difficulty in defining NCR ligands, the 
NCRs have demonstrated their contribution in NK-mediated cytotoxicity as blocking 
experiments correlated with lower killing of target cells [26, 28]. In contrast to the 
NCRs, NKG2D has well-established ligands, including the stress induced MHC class I 
chain-related A and B proteins (MICA and MICB) and the UL-16 binding proteins 
(ULBP1-4) [29, 30]. The activating NKG2D is known for its antiviral and antitumor 
properties [31-33]. NKG2A and NKG2C, belonging to the same family as NKG2D, 
both recognize HLA-E but provides opposite signals after interaction [34]. NKG2A 
delivers an inhibitory response, while NKG2C is associated with NK activation. These 
receptors are only a few of those existing, but demonstrate NK cells ability to detect 
virus infected- and transformed cells. 
 
Figure 1. Missing-self recognition. The NK cell response is regulated by a balance of both activating and 
inhibitory signals. The figure is reused with permission from the Nature Publishing Group [35]. 
 
Upon activation, NK cells may respond by direct cytotoxicity and by the release of 
cytokines and chemokines. NK cells are able to directly kill transformed cells by the 
exocytosis of lytic granules containing perforin, granzymes and Fas-ligand. Perforin 
participates in the permabilization of target cell membrane, facilitating for proteolytic 
enzymes such as granzyme to activate caspases and induce apoptosis in the target cell 
[36, 37]. Additionally, NK cells stimulate inflammatory responses by secreting 
interferon-γ (IFN-γ), tumor-necrosis factor-α (TNF-α) and granulocyte/macrophage 
colony-stimulating factor (GM-CSF) [38-40]. IFN-γ inhibits viral replication and 
contributes to many other immunostimulatory effects while TNF-α induce apoptosis by 
engaging cell-death receptors on target cells [41, 42]. GM-CSF stimulates stem cells to 




Mice and humans use two structurally unrelated receptor families, the Ly49 and KIRs, 
to recognize MHC class I molecules [44]. The two families have evolved independently 
but developed similar ways to maintain a balance between self-tolerance and detection 
of loss of self, representing an example of convergent evolution [45]. Studies of Ly49 
have made a huge contribution to the knowledge about all variable receptors for MHC 
class I, however the section below is dedicated to human KIRs as they are the main 
focus of paper I, II and III. 
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1.2.1 KIR gene structure and nomenclature 
The KIR gene cluster is located on chromosome 19, encoded within a region of the 
Leukocyte Receptor Complex (LRC) [46]. To date, the KIR gene family consists of 15 
genes and 2 pseudogenes [47, 48]. The nomenclature for KIRs is based on structural 
characteristics of the KIR proteins. The first two characters following the KIR acronym 
describe the extracellular part of the protein consisting of two or three Ig-like domains, 
hence KIR2D or KIR3D. The third character in the name defines the transmembrane 
and cytoplasmic region, which refers to a short (S) or long (L) cytoplasmic tail or a 
pseudogene (P) [49]. The length of the tail is also functionally relevant as the short tail 
is associated with the activating form of KIRs whereas the long tail is associated with 
inhibitory KIRs. Activating KIRs possess a charged amino acid in its transmembrane 
region that can interact with the signaling molecule DAP-12, which generate activating 
signals via the immunoreceptor tyrosine-based activating motif (ITAM). In contrast, the 
inhibitory KIR possesses immunoreceptor tyrosine-based inhibitory motifs (ITIM) in 
its cytoplasmic tail, and consequently provides inhibitory downstream signals [50-52]. 
However, the first three characters are not sufficient to distinguish between all 15 KIR 
genes. Therefore, a final character was added to mark the number of the gene encoding 
a specific structure [49]. 
 
The KIR gene locus displays an extensive diversity between individuals. Generally, 
KIR haplotypes contain between 9 and 15 genes , although studies of gene copy number 
variations have revealed a KIR haplotype with only 4 genes [53-55]. Additionally, KIR 
genes contain variable sites, which result in multi-allelic polymorphism [53, 56-58]. 
Hence, it is very unlikely that two randomly selected individuals share the same KIR 




Figure 2. KIR gene organization. The upper haplotype represents KIR gene content in group A 
individuals while the lower haplotype represents group B individuals with some additional inhibitory and 
activating KIR genes. Known KIR ligand specificities are illustrated above the KIR genes. Adapted from 
[59]. 
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1.2.2 KIR gene haplotypes 
Based on KIR gene content, individuals can be divided into two different haplotypes 
termed A and B [53]. The number and combination of KIR genes present distinguish 
the two haplotypes. Haplotype A individuals have a non-variable gene organization and 
possess only long tailed KIRs with the exception of KIR2DS4 [60, 61]. Four of these 
KIR genes are called framework genes, as they are present in virtually all individuals 
(3DL3, 3DP1, 2DL4 and 3DL2). Moreover, 3DL3, 2DL4 and 3DL2 define the start, 
middle and end of the KIR locus, and between them are two regions of variable gene 
content known as the centromeric and telomeric regions [62]. In haplotype A 
individuals, these two regions may contain five other genes, 2DL1, 2DL3, 3DL1, 2DP1 
and 2DS4.  Group B haplotypes display larger variation in KIR gene content, where 
additional inhibitory and activating receptors, known to be absent in group A 
haplotypes, may be included (2DL2, 2DL5A/B, 2DS1, 2DS2, D2S3, 2DS5 and 3DS1) 
[60, 61]. Noteworthy, the 2DL2 and 2DL3 genes are actually two alleles that segregated 
from the same locus and could in fact be seen as framework loci as most individuals 
possess one or the other. The same holds true for the 3DL1 and 3DS1 genes [63].  
 
The frequency of haplotype A and B groups differ between ethnically defined 
populations [64-66]. The occurrence of group A haplotypes in the Japanese population 
is high, where around 75 percent of the population exhibits a dominance of the 
inhibitory KIR genes [67]. In contrast, Australian Aborigines demonstrate the opposite 
separation of haplotypes and consist of only 1.5 percent haplotype A individuals [66]. 
As it will be discussed in chapter 1.5, the distribution of haplotype A and B groups may 
endow different ethnic backgrounds with disparate abilities to withstand different 
diseases.  
 
1.2.3 KIR ligands 
The expressed KIRs interact with HLA class I molecules, and NK cells respond 
functionally if self-HLA is lacking on adjacent cells. To date, not all KIR ligands are 
known, the ligands studied in greatest detail are those sensed by the inhibitory KIRs. 
The ligands defined so far include HLA-C allotypes with aspargine or lysine at position 
80, sensed by KIR2DL2/3 and KIR2DL1 respectively. Allotypes with aspargine and 
lysine are referred to as C1 and C2 [68, 69]. In recent years, it has been suggested that 
KIR2DL2 possess the ability to sense both C1 and C2 ligands [70, 71]. Other ligands 
detected by one of the major inhibitory KIRs are HLA-A and HLA-B alleles with Bw4 
motifs at position 77-83, which are recognized by KIR3DL1 [49]. KIR3DL2 has been 
shown to recognize HLA-A3/A11, where the interaction is said to be peptide dependent 
[72]. Additionally, KIR2DL4, which distinguish itself from the other KIRs because of 
its ability to act as both an activating and inhibitory receptor, has shown to bind the 
non-classical HLA-G molecule. Fetal derived placental cells express HLA-G and 
KIR2DL4 is therefore considered to play a role in immune tolerance in pregnancy [73, 
74]. The activating receptors KIR2DS1, KIR2DS2 and KIR3DS1 display similar 
extracellular domains as their inhibitory counterparts and are thus thought to share 
binding specificities. KIR2DS1 and KIR2DS2 have shown to weakly bind to HLA-C2 
and HLA-C1 respectively [75, 76], however interaction between KIR3DS1 and Bw4 
has not been confirmed. KIR2DS4 is believed to recognize HLA-C*1601 (C1) and 
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HLA-C*0501 (C2) and HLA-A*1102 [77]. To date, KIR2DS3, KIR2DS5 and 
KIR2DL5, have no known ligands.  
 
1.2.4 Transcriptional regulation of KIR genes 
The transcriptional regulation of KIR genes has shown to be a complex procedure 
determined by the activities from three different promoters. Cichocki et al. recently 
reviewed the subject and proposed an integrated model for KIR transcriptional 
regulation [78]. During the first stages of development, a promoter located in the 
second intron of the KIR gene initiates antisense transcription. These transcripts are 
only found in NK progenitors and could be part of an initial promotion of DNA 
methylation [78]. As the cells mature, the distal promoter, located upstream of KIR 
genes, initiate forward transcription [79]. The distal promoter contains a c-Myc binding 
site that is sensitive to IL15 stimulation [80]. Hence, during the CD56bright stage, when 
the IL15 receptor complex is expressed, stimulation through the receptor drives 
transcription [81]. The third promoter, the proximal promoter, has probabilistic 
bidirectional activity, where the direction of activity has been linked with the 
methylation status of the promoter as well as KIR expression [82-85]. The antisense 
transcript from the proximal promoter is able to form double-stranded RNA together 
with the transcript from the distal promoter, which can be further processed into a 
smaller 28-base antisense PIWI-like RNA [83, 86]. This 28-base RNA helps to 
maintain the hypermethylated status of the proximal promoter, and thereby preventing 
KIR expression. In contrast, initiation of forward transcription form the proximal 
promoter allows stable KIR gene transcription [86]. 
 
The switch from reverse to forward transcription by the proximal promoter seem to be 
the key in understanding what drives KIR expression. Forward transcription is initiated 
after the transition from CD56bright to CD56dim NK cells, but is so far not linked to any 
specific signaling event. Additionally, considering that KIR genes share >90% 
homology of promoter sequence, it would be interesting to know whether 
demethylation of the proximal promoter occurs in a specific or random manner [86, 
87]. Ultimately, the transcriptional regulation of KIR genes leads to a stochastic 
expression of KIR proteins at the cell surface, where some NK cells do not express a 
single KIR while other NK cells express combinations of multiple KIRs [88, 89]. These 
expression patterns are part of the main focus in the current thesis and is discussed in 
detail in chapter 3.2. 
 
  
1.3 NK CELL EDUCATION 
The "missing self" hypothesis proposed by Kärre in the 80ies provided insights into 
how target cells could be identified and killed by NK cells [12]. Soon thereafter, the 
discovery of Ly49 and KIRs gave a molecular explanation to the hypothesis and led to 
the assumption that all NK cell must express at least one self-Ly49/KIR to ensure self-
tolerance [90]. However, there were a few puzzling findings that could not be explained 
by the "missing self" theory alone. Mice deficient of MHC class I molecules did not 
display auto-reactivity as predicted by the missing self theory, but rather a 
hyporesponsive NK cell population [91]. Moreover, in MHC class I sufficient mice, a 
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subpopulation of NK cells was observed that lacked all known self-MHC specific 
receptors but yet responded poorly to MHC deficient cells [92]. More recently, similar 
observations were made in humans, where hyporesponsive KIR negative NK cells were 
detected in blood [89, 93]. Overall, these findings demonstrated that there are certain 
situations were NK will not kill target cells deficient in MHC class I expression and 
that NK cells without class I-specific receptors are allowed to exist in a hypofunctional 
state. 
 
In 2005, Kim et al. provided an explanation to the previously confounding discoveries. 
The authors presented a model where NK cells gained functional competence by 
expressing a Ly49 receptor that recognized a self-MHC class I receptor. This MHC 
class I dependent functional maturation was termed licensing [94]. However, other 
definitions have been used to describe this process [93, 95, 96], and in this thesis we 
will hereafter use the term education. NK cells that lacked inhibitory receptors capable 
of engaging self-MHC remained uneducated, and were therefore hypofunctional and 
self-tolerant. 
 
NK cell education has also shown to occur in humans, where the inhibitory KIR2DL1, 
2DL2, 2DL3 and 3DL1 confer functional responses in NK cells harboring the cognate 
ligands [93, 97]. Additionally, it has been demonstrated that the activating KIR2DS1 
also plays a role in the education process. Contrary to inhibitory KIRs, KIR2DS1 
positive NK cells tunes down responsiveness to target cell stimulation in C2/C2 
individuals [98]. This effect was noticeable in KIR2DS1 single positive cells, as well in 
cells co-expressing NKG2A or KIR2DL3. However KIR2S1 positive NK cells co-
expressing KIR2DL1, the inhibitory receptor that shares ligand with KIR2DS1, did not 
display similar hypofunctionality. Altogether, it seems like inhibitory KIRs upregulate 
NK cell function while activating KIRs may tune down responsiveness, presumably to 
ensure tolerance. 
 
1.3.1 Models of NK cell education 
Many groups have now reached a consensus that the interaction between a self-MHC-
binding receptor and a self-MHC is necessary in order for education to occur. Kim et 
al. has also shown that the ITIM motif is indispensible in the downstream signaling to 
confer education [94]. However, it is still unclear by which mechanisms the 
engagement of a MHC-specific receptor leads to functional competence. So far, two 
alternative models have been put forward, the “arming” model by Yokoyamas group 
and the “disarming” by Raulets group [95, 99-101]. In the “arming” model, NK cell 
education is directly induced by the engagement of MHC class I specific receptors. In 
essence, the inhibitory self-MHC receptor will itself transmit the positive signal 
required for education. In contrast, the “disarming” model suggests that NK cells are 
constantly stimulated through an undefined self-specific activation receptor, and that in 
absence of self-MHC recognition the strong activation signals result in a state of 
anergy. The loss in responsiveness could be reversed by the engagement of an 
inhibitory self-MHC receptor, which ensures self-tolerance. 
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1.3.2 MHC interactions 
The binding between Ly49 and MHC class I has shown to be similar when the NK cell 
confer education or effector inhibition. Both interactions involve Ly49 to bind the same 
recognition site on MHC class I [102-104]. It has been debated whether the interaction 
with the MHC molecule is delivered via cis- or trans-binding (Ly49-MHC interaction 
occurs at the cell surface of the same cell or between two different cells). Chalifour et 
al., constructed a mutant Ly49 receptor where the flexible region of the receptor was 
absent, resulting in a Ly49 that could only provide trans-binding to MHC class I. NK 
cells from these transgenic mice did not appear to be properly educated, although the 
receptor could still provide inhibitory signals [105]. Undoubtedly, these results 
indicated that education is regulated through cis-interactions between Ly49 and its 
MHC ligand. However, recent findings oppose these conclusions. Two independent 
studies showed that NK cells that were adoptively transferred from MHC deficient 
mice into MHC sufficient mice, or vice versa, became re-educated in their new 
environment [106, 107]. Uneducated NK cells from a MHC deficient background 
became educated and showed functional competence after being transferred to MHC 
sufficient mice. In contrast, educated NK cells from a MHC sufficient background 
became anergic after transfer to a MHC deficient environment. These observations 
would suggest, in contrast to Held et al., that cis interactions are not sufficient for NK 
cell education. 
 
Additionally, the latter studies also reveal the dynamic nature of education in mature 
NK cells. Initially, NK cells were thought to be educated during development in the 
bone marrow [94]. Instead, NK cells may be capable of acquiring functional 
competence throughout their lifespan. In agreement with this notion, several groups 
have suggested that NK cell education is not a one-time event but rather the net sum of 
numerous continuously occurring MHC interactions [108-110]. The more signals an 
NK cell receives, the stronger responses it will be able to mount when stimulated. 
These data suggests that NK education is not an “on or off” process, but more similar to 
a rheostat with tuning events occurring continuously along the lifespan of NK cells.   
 
  
1.4 SELECTION MODELS FOR REPERTOIRE FORMATION 
Early models for NK cell selection were based on mouse studies, where the emphasis 
was put on Ly49 expression in mice with different MHC class I environments [90, 
111]. Three major findings suggested that Ly49 expression was influenced by the MHC 
class I environment. First, mice deficient of β2-microglobulin (i.e. mice that lack MHC 
class I expression and therefore also ligands to Ly49) displayed higher frequencies of 
Ly49 positive cells than wild-type mice [111, 112]. Secondly, when a specific Ly49 
ligand was introduced into a mouse that previously been deficient of that same ligand, 
an NK cell subset arose that was capable of rejecting bone marrow from mice lacking 
that specific ligand [113, 114]. Thirdly, co-expression of two self-Ly49s was less 
frequent in mice possessing the corresponding ligands compared to mice lacking the 
same ligands [111, 115].  
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The fact that Ly49 seemed to decrease in frequency, expression levels and co-
expression when the cognate ligand was present, made Raulet speculate that these 
restrictions occur in order to provide NK cell repertoires that are better in 
discriminating MHC class I-loss variants. By disfavoring NK cells expressing multiple 
self-Ly49s, the selection process assures that cells within the NK cell compartment is 
capable of detecting loss of a single MHC class I molecule. Additionally, NK cells 
need to express at least one self MHC-specific receptor to assure self-tolerance [90]. 
 
Since Ly49 and MHC class I genes are located on different chromosomes, a mouse may 
inherit a Ly49 without simultaneously inherit the corresponding MHC class I gene 
[116]. Hence, according to Raulets model, all Ly49 genes may still be transcribed, both 
self- and nonself Ly49s. However, gene transcription is followed by a selection process 
that reshapes the NK cell repertoire based on interactions with MHC class I molecules. 
The two proposed models that describe this process are referred to as “the sequential 
Ly49 gene activation model” and “the two-step selection model”.  
 
1.4.1 The sequential selection model 
In this model, Ly49s are constantly and sequentially expressed at the cell surface. The 
expression of next coming Ly49 is random, hence both self and nonself receptors are 
transcribed in a variegated fashion. During the accumulation of receptors, NK cells are 
continuously tested for interactions with self-MHC. When sufficient inhibition occurs 
through the interaction between Ly49 and MHC, acquisition of new receptors ceases 
and the cell develops into a mature NK cell (see Figure 3). Notably, the interaction is 
dependent on the affinity between the receptor and ligand, and there is a threshold of 
inhibition that needs to be achieved to allow selection and thus assure self-tolerance. In 
summary, the sequential selection process generates NK cell repertoires that are both 
tolerant to self and able to sense loss of a single MHC [90]. 
 
1.4.2 The two-step selection model 
The two-step selection model is fairly similar to the positive and negative selection of T 
cells in the thymus, where cells need to recognize self-peptides through MHC although 
not bind too strongly [117]. Here, the NK cell repertoire is randomly formed at an 
initial stage, and then followed by two selection events. At the first step, NK cells 
expressing at least one self-Ly49 will be selected. Secondly, all NK cells that express 
too many self-receptors will be selected against. As in the sequential selection model, 
there is a threshold of inhibition that needs to be reached at both steps. Depending on 
the signaling threshold of these steps, NK cells expressing more than one self-Ly49 
may be allowed if the first self-Ly49 cannot provide a strong enough inhibitory signal 
[90]. 
 
Work in this this thesis (paper II) have generated results that challenges the above 
described selection models. In chapter 3.2, we will revisit the models and see how they 
relate to our observed data. In contrast to the selection models, we propose that a mere 
random combination of available receptors is sufficient to provide the necessary 
requirements for broad NK cell specificities and self-tolerance. 
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Figure 3. The sequential selection model. A) The sequential selection model postulates that NK cells 
sequentially express KIRs until a threshold for inhibition is reached, leading to the fixation of the KIR 
repertoire for that particular cell. B) Predictions of how KIR repertoires appear in individuals with 1 to 3 
KIR ligands. The figure is reused with permission from Elsevier [118]. 
 
 
1.5 KIR IN HEALTH AND DISEASE 
Because of the large variability of the KIR and MHC loci, individuals display NK cell 
repertoires with a substantial diversity of possible KIR-HLA combinations. These 
variegated KIR-HLA repertoires may potentially endow NK cells with different 
abilities to recognize and respond to infected- or transformed cells. Therefore, studies 
to correlate disease incidence with the presence of specific KIR and HLA genes have 
been performed [44, 63, 119]. To date, disease associations coupled to various KIR and 
HLA combinations have been observed in various clinical settings, such as infection, 
autoimmunity, reproduction and cancer and HSCT, some of which are briefly 
summarized below. 
 
1.5.1 Immunogenetic disease association studies of KIR and HLA 
The combination of KIR3DS1 and its putative ligand HLA-B Bw4-80I has been 
associated with slower progression to AIDS in HIV infected individuals [120]. The 
correlation was supported by the observation that KIR3DS1 positive cells inhibit HIV-1 
replication in infected cells that express Bw4-80I [121]. Additionally, high expressing 
KIR3DL1 alleles have also been associated with lower viral load in Bw4-80I positive 
individuals, which indicates that both the activating and inhibitory form may play a role 
in HIV infection [122]. Moreover, resolution of acute hepatitis C virus (HCV) infection 
was favored in individuals homozygous for both KIR2DL3 and HLA-C1 [123]. 
Between KIR2DL1, KIR2DL2 and KIR2DL3, the latter one is predicted to provide the 
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weakest inhibition through interaction with its cognate ligand, which could provide less 
constrained NK cells responding to the infection [124, 125]. 
 
Autoimmune diseases are usually correlated with the activating forms of KIRs, and 
therefore also the group B KIR haplotype. The combination of KIR2DS1 and HLA-
Cw*06 (HLA-C2) has shown to increase predisposition to psoriasis [126]. The 
susceptibility to psoriatic arthritis increases with the presence of KIR2DS1 and 
KIR2DS2, as well as the absence of HLA-C1 or HLA-C2 [127, 128]. Activating KIRs 
have also been associated with other autoimmune diseases, such as type I diabetes [129, 
130], scleroderma [131] and rheumatoid vasculitis [132]. However, although haplotype 
B individuals may be in greater risk of developing an autoimmune disease, their 
genotype is favorable in women during pregnancy as pre-eclampsia occurs most often 
in haplotype A women carrying an HLA-C2 fetus [133]. 
 
1.5.2 Cancer and transplantation settings 
Numerous investigations have analyzed HSCT settings, in attempts to link the KIR and 
HLA genotype of patients and recipients to treatment outcome. HSCT is a treatment for 
hematopoietic malignancies such as leukemia, myelodysplastic syndrome and 
lymphoma. The strategy in allogeneic HSCT is to replace the patients aberrant 
hematopoietic system with one from a healthy donor, and to eradicate all tumor cells in 
the process [134]. The treatment was one of the first to be individualized to each patient 
after the discovery of the importance of HLA compatibility (HLA-matching) between 
donor and recipient pairs. A common complication that can appear after mismatched 
transplantation is graft-versus-host disease (GVHD), which results from an attack of 
normal host tissues by donor-derived immune cells [135]. However, although this 
immune-mediated complication can be potentially life-threatening, it has also been 
associated with a decreased rate of malignant relapse. This beneficial outcome is linked 
to a graft-versus-tumor (GVT) effect that arises when donor effector cells attack 
residual malignant cells [136]. 
 
To reduce the risk of GVHD in transplantation settings, donors are HLA-matched with 
their recipient. In situations where fully matched donors are not available, a feasible 
option is to use stem cells from an HLA-mismatched relative who shares one HLA 
haplotype. Under such circumstances, it is challenging to maximize the GVT effect 
without inducing GVHD [137]. In accordance to the “missing self” theory, NK cell 
alloreactivity, and consequently GVT effects, is predicted to take place in 
transplantation over HLA barriers [13]. Considering the rules of NK cell education, 
such alloreactivity may only occur when the recipient lack one or more KIR ligands 
present in the donor [94]. Indeed, in 2002 Ruggeri et al. demonstrated an NK-cell 
mediated GVT effect in human transplants. Protection against leukemia relapse was 
observed in acute myeloid leukemia (AML) patients receiving T cell depleted 
hematopoietic stem cells from haploidentical donors. Noteworthy, no GVHD was 
detected [138]. Unfortunately, succeeding investigations have not been as 
straightforward, and have not been able to reproduce the same success rate. During the 
last decade, the influence of KIR-HLA mismatch on outcomes in mismatched HSCT 
has been highly variable, linking KIR ligand mismatch to both beneficial and damaging 
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effects [139]. To date, the role of NK cell alloreactivity in mismatched HSCT remains 
unclear.  
 
1.5.3 Reconstitution of the KIR repertoire after HSCT 
Apart from being a very important treatment modality for patients with hematological 
malignancies, HSCT also offers a unique opportunity to follow the reconstitution of 
human KIR repertoires. In paper III, such analyses were performed to study NK cell 
differentiation. The studies revealed a specific pattern of sequential acquisition of NK 
cell receptors and provided a basis for proposing a new model of late stage NK cell 
differentiation that will be discussed in chapter 3.3. Previous studies have used the 
transplantation setting to investigate whether the NK cell repertoire changes as it is 
exposed to a new HLA environment. By following patients after HLA matched and 
mismatched transplantations, the authors observed that donor derived NK cells 
displayed donor-like pattern of KIR expression, distinct from the recipient before 
treatment [140]. These data suggest that regeneration of the KIR repertoire is not 
influenced by recipient HLA, but rather set by the KIR genotype of the donor. 
 
1.5.4 Refining KIR association studies 
Noteworthy, most studies associating KIRs and their ligands with diseases are based on 
genetic data and do not consider the actual expression of KIR genes. Although a certain 
set of KIR genes are present in the genome, KIRs may be expressed at different 
frequencies, with various surface expression levels and having different binding 
affinities to their ligands. In paper I, we estimated the size of the alloreactive NK cell 
subset in potential transplantation donors based on KIR expression frequencies. The 
result showed great variation in predicted alloreactivity, which could not have been 
detected by genotyping alone. Hence, it will be interesting to follow future 
investigations linking protein expression data to already existing gene and disease 
associations. To correlate current findings with protein expression data could both 
strengthen existing theories and provide new ones. 
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2 AIM OF THE THESIS 
The overall aim of this thesis was to gain further insights into the formation of the KIR 
repertoire. More specifically, our study objectives were as follows: 
 
Paper I. Due to inconsistent results from mismatched HSCTs, we reasoned that the 
genetic algorithm for donor stratification is insufficient to predict NK cell 
alloreactivity. Our aim was to estimate the size of the alloreactive NK cell subset in 
potential donors based on phenotypical data. 
 
Paper II. NK cells ability to detect and eradicate virus infected- and transformed cells 
is influenced by the individual’s KIR repertoire. However, little is known about how 
these KIR repertoires are formed. We aimed to increase our knowledge of the process 
by relating data of observed KIR repertoires to previously defined selection models. 
More specifically, we wanted to investigate whether selection by self-HLA class I 
molecules was necessary to establish KIR repertoires with the ability to sense loss of 
single self-HLA while preserving self-tolerance. 
 
Paper III. The increasing knowledge about the phenotypical and functional 
heterogeneity of mature NK cells indicate that the population could perhaps be 
subdivided into smaller subsets representing different stages in development. Our aim 
was to study characteristics of NK cell differentiation at steady state and in settings of 
immune reconstitution.  
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3 RESULTS AND DISCUSSION 
 
3.1 ACQUISITION OF KIRS 
In the late 90ies, it was questioned whether variegated Ly49 repertoires could be the 
result of random and independent events [90]. To investigate this the “product rule” 
was applied to experimental Ly49 expression data. The product rule is a special case of 
Bayes rule for random and independent events, and states that the probability of 
expressing two Ly49 (or KIRs) equals the product of the probabilities of expressing 
each one of them.  
 ! !"#1 ∩ !"#2 = !(!"#1)×!(!"#2), where the probabilities for expression are 
estimated from the actual expression frequencies. 
 
Studies of Ly49 expression data in mice were conducted on three different mice strains. 
The authors used the product rule as a tool to study if acquisition of upcoming Ly49 
was dependent on previously expressed Ly49s. The conclusions drawn from these 
experiments was that the expression patterns of Ly49 seemed to follow those predicted 
by the product rule, hence Ly49 acquisition was considered as an event independent of 
previously expressed receptors [90]. In line with these investigations, Valiante et al. 
preformed equivalent analyses on human NK cell clones. Observed and expected 
values coincided and the results agreed with prior observations in the mouse [88]. 
Consequently, it was concluded that Ly49/KIR acquisition was a random event that 
was independent of expression of other Ly49/KIRs. 
 
3.1.1 KIR acquisition probabilities increase with cellular KIR 
expression 
Technological advancements of flow cytometry allowed us to reapply the product rule 
on data sets with higher resolution of KIR expression patterns. In paper II, we detected 
a small but significant deviation from the product rule when observed and expected 
frequencies were compared in NK cells co-expressing two KIR receptors. The 
deviation became more evident when co-expression of three or four receptors was 
examined (paper II, Figure 2). The observed frequencies of KIR expression were 
distinctly higher than what the product rule predicted. This led us to speculate that KIR 
acquisition is either a nonrandom event or dependent on previously expressed KIRs, or 
both.  
 
To further investigate these possibilities, we compared the observed KIR expression 
data with theoretical values generated by statistical distributions describing random 
acquisition of KIR expression that were either independent or dependent on previously 
expressed KIRs. We first tested the compliance of our data to a binomial distribution, a 
distribution similar to a perfect fit with the product rule since both describe random and 
independent events. As expected, our data diverged from the binomial distribution 
showing lower frequencies of NK cells with one single KIR but higher frequencies of 
cells with multiple KIRs than predicted (paper II, Figure 3A). In a second attempt, we 
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continued to use the binomial distribution but made the assumption that the probability 
of KIR acquisition could be estimated by expression frequencies of the individual 
KIRs. Thus in contrast to the plain binomial distribution that assume equal expression 
probabilities for each of the four KIRs, this adaptation of the binomial distribution 
describes how the KIR repertoire would appear if KIRs were given discrete 
probabilities. However, this distribution did not provide a suitable fit with our observed 
data (paper II, Figure 3B).  
 
To address the question whether KIR acquisition could be dependent on previously 
expressed KIRs we searched for a mathematical distribution that could describe how 
the probability of KIR acquisition changes as cells acquire additional receptors. The 
beta-binomial distribution with best fit to the observed data suggested that the 
probability of acquiring a KIR is higher the more KIRs the cell already expresses at the 
cell surface (paper II, Figure 3C). These results are, at least in part, in line with a 
recent study that investigated whether inhibitory KIR expression was impacted by the 
expression of other KIRs. Their analysis, based on expression patterns of three 
inhibitory KIRs, showed that KIR expression is not always equiprobable, but indeed 
influenced by already expressed KIRs [97]. Although our data suggest that the 
probability of KIR acquisition is dependent on previously expressed KIRs, the 
underlying mechanism is still unknown. 
 
NK cells sense loss of self-HLA [13]. However, if target cells loose only one self-HLA 
allele, NK cells expressing multiple KIRs would be inhibited and fail to eliminate the 
targets. Under such circumstances, NK cells with just one KIR would be the best 
candidates to eradiate the transformed target cells. Although human NK repertoires 
mainly consist of NK cells expressing only one or two KIRs, one can still ask whether 
there is any beneficial consequence of possessing NK cells with multiple KIRs. Indeed, 
it has been shown that NK cell cytotoxicity increases with the number of self-KIRs, 
whereas co-expression of nonself-KIRs does not change the responsiveness [97]. As 
previously mentioned, we detected that the NK cell subset expressing multiple KIRs is 
almost twice as common as expected by independent KIR acquisition. Whether the 
small subset of highly educated cells (around 1.7% of all NK cells) expressing 4 
inhibitory KIRs fulfills any physiologically relevant role remains elusive. 
 
3.1.2 The time frame for KIR acquisition 
It is unclear whether KIR acquisition is a process where multiple KIRs are expressed at 
the cell surface in a relative quick fashion or if it is a process that spans over several 
days or even weeks. KIR expression is largely genetically hardwired, and depends on 
the sequence of KIR alleles and promoters [141]. Since KIR promoters are almost 
identical, one may speculate, that there could be competition for transcription factors, 
and that small differences in sequence of the promoters may enhance or reduce the 
recruitment of beneficial transcription factors to switch transcription of the proximal 
promoter in the sense direction [82, 87, 141]. Although it seems likely that such events 
occur rather rapidly, the actual time frame remains elusive. Another possibility of how 
accumulation of multiple KIRs at the cell surface could appear is by a continuous 
sequential acquisition of KIRs that may potentially take place over longer time periods. 
The fact that the probability of expressing a new KIR seems dependent on previously 
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expressed KIRs argues for serial acquisition of KIRs. Moreover, as we shall come back 
to in relation to paper III (chapter 3.3), NK cells with multiple KIRs co-express CD57 
to a higher extent than NK cells with few KIRs, indicating that NK cells with many 
KIRs have reached a higher differentiation stage (paper III, Figure 2B).  Additionally, 
cultivated CD57 negative NK cells with multiple KIRs upregulated CD57 to a higher 
extent than CD57 negative NK cells with few or zero KIRs in the presence of IL-2, 




3.2 FORMATION OF THE KIR REPERTOIRE IN ABSENCE OF 
SELECTION 
Since 1997, when Raulet first postulated the sequential selection model and the two-
step selection model, not many efforts have been made to challenge these theories. It 
seemed logical that, like T cells, NK cells should have some sort of selection process 
where cells responding too weak or too strong were eliminated.  NK cells had to 
express at least one KIR receptor to be tolerant but not too many KIR receptors that 
could interfere with their functionality [90].  
 
The MHC class I molecules have always been obvious candidates to drive selection of 
Ly49/KIR expression. However, studies in mice and humans have pointed in somewhat 
different directions. As discussed in chapter 1.4, early findings in mice showed a 
tendency of MHC class I influence on Ly49 expression, where NK cells that expressed 
a Ly49 specific for cognate MHC were less likely to express yet another Ly49 receptor 
[111, 142]. Initial studies in humans did not find any significant influence of HLA on 
the formation of the KIR repertoire [143, 144]. Instead, most studies argued that KIR 
genotype was the main determinant of KIR expression [145, 146]. Shilling et al. 
studied the KIR repertoire in sibling pairs, where KIR and HLA genes had been 
inherited identically or disparately between siblings. Whereas KIR identical siblings 
had similar KIR repertoires, HLA identical but KIR disparate siblings had variegated 
KIR repertoires. Hence, it was concluded that KIR expression is essentially determined 
by the encoding KIR genes. Although a minor effect of HLA-mismatch was noted, 
presence or absence of the specific KIR ligands did not seem to matter [146]. However, 
a few years later, Parham’s group reported that the presence of a cognate ligand 
increases KIR expression, but the presence of other ligand-receptor pairs cause 
downregulation of each receptor [147]. These observations were the first to support a 
role for HLA in KIR repertoire skewing. 
 
3.2.1 Challenging predictions of the sequential selection model 
In paper II we wanted to address the possible influence that HLA might have on 
formation of the KIR repertoire. The postulated models of NK cell selection give rise to 
a number of predictions. One prediction is that there should be a deletion of unwanted 
subsets, such as cells with no self-KIRs. In line with previous data reported by Yawata 
et al., screening the KIR repertoire of 44 individuals, all possible combinations of NK 
cells expressing zero, one, two, three or four KIRs were present [148](paper I). This 
shows that there is no deletion of NK cells during development due to absence of self-
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KIRs or expression of nonself-KIRs. A second prediction derived form Raulet’s models 
is that if KIR expression is presumed to cease after acquisition of a self-KIR, then 
individuals with few KIR ligands would have greater numbers of NK cells expressing 
multiple KIRs compared to individuals with a high number of KIR ligands (Figure 
3B). However, in our cohort, individuals with one, two or three KIR ligands showed 
similar patterns of KIR expression (paper II, Figure 5A). Although most cells 
expressed either one or two KIRs, individuals with many strong KIR ligands had 
similar frequencies of cells with 4 KIRs as those with only one KIR ligand. A third 
prediction is that the selection events should enrich for NK cells that express self-
specific KIRs so that these become more frequent than in the “preselection” repertoire 
having a random combination of all available receptors. Earlier, we discussed the 
increasing probabilities of acquiring KIRs, where expression of new KIRs was 
dependent on previously expressed KIRs (chapter 3.1.1). Importantly, we could not 
find support for an underlying selection event that made NK cells preferably express 
self-KIRs. Instead, the distribution of self and non-self KIR receptors was completely 
random and represented the outcome of the different ways to combine various KIRs. 
As an example, lets consider the outcome of combining two KIRs in a donor 
possessing four inhibitory KIR genes and two ligands (Figure 4). This particular 
example is highly relevant for the entire NK cell compartment since most donors 
possess two self-ligands and many NK cells express two KIRs. In this case, there is a 
50% probability to express a self-KIR and 50% to express a non-self KIR. The 
distribution of all possible receptor combinations illustrates that there is 1/6 ways to 
express two self-KIRs, 4/6 ways to express one self and one non-self KIR, and 1/6 
ways to express two non-self KIRs. Consequently, without any selection process, five 
out of six NK cells will be equipped with at least one self-KIR receptor and four of 
these will have only one self-specific KIR. Unexpectedly, the observed repertoires 
matched very well with the theoretical values obtained from such combinatorial 
calculations. Hence, our data argue against a selection process that further shape the 
randomly generated repertoires as predicted by the here challenged models. 
Importantly, the randomly formed NK cell receptor repertoires still fulfill many of the 
properties required to sense loss of a single self-HLA molecule, with preserved 
tolerance to self. Our data are, in part, in line with a previous investigation showing that 
NK cell repertoires are dominated by cells expressing self-KIRs [97]. In contrast to our 
conclusions, the authors argue that the result reflects a general bias towards expression 
of self-KIRs. However the study did not consider the number of self-ligands, and thus 
does not reflect the number of ways to combine self- and nonself-KIRs. 
 
3.2.2 Discrimination between weak and strong KIR ligands 
In paper II, we did not consider the polymorphism of KIR and HLA. In a recent paper 
by Peter Parham’s group it was suggested that NK cells undergo a “repertoire 
calibration” step to generate equally responsive KIR repertoires in human individuals. 
Yawata et al. propose that donors with one strong KIR-HLA combination have KIR 
dominated repertoires, while donors with either too many or with lack of strong KIR-
HLA interaction have NKG2A dominated repertoires [148]. The expression of NKG2A 
would then serve to buffer the overall NK cell responses in individuals, resulting in 
more even capacity in functionality between individuals (discussed further in chapter 
3.3.5). To strengthen our model we recalculated our data excluding weak ligands, such 
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as A23 and A24 [148]. We also excluded HLA-A3/11 from our calculations since this 
ligand have not shown to have any educational effect on KIR3DL2 positive cells. 
Reanalyzing our data, taking only strong ligands into account, strengthen the 
impression of a completely random distribution of receptors (paper II, supplemental 
Figure 4). 
 
Figure 4. Random distribution of self- and nonself KIRs in an individual possessing four inhibitory KIR 
genes and two KIR ligands. In NK cells expressing two KIRs, there are four times as many ways to 
combine one self with one nonself KIR, than to combine two self or two nonself KIRs. The figure is 
reused with permission from Elsevier [118]. 
 
 
3.2.3 Evidence for a ligand-instructed model 
Our results were recently challenged by Schönberg et al., where the authors detected a 
modulating affect by HLA-C and KIR2DL genotype on the KIR repertoire [70]. The 
authors proposed a ligand-instructed model, and suggested that KIR2DL1 expression 
and function is dependent on HLA-C genotype and the presence or absence of the 
KIR2DL2 gene. In haplotype A donors, the frequency of NK cells expressing KIR2DL1 
was higher in C2/C2 individuals, and the frequency of NK cells expressing KIR2DL3 
was higher in C1/C1 individuals, which indicated a selection of NK cells expressing 
self-KIR receptors. Notably, the effect disappeared when the total haploB population 
was analyzed but reappeared when KIR2DL2/S2 positive haploB individuals were 
excluded from the same analysis.  
 
The presence of KIR2DL2 seemed to suppress expression of KIR2DL1 on NK cells but 
did not downregulate the overall response of the population since KIR2DL2 positive 
NK cells showed not only responsiveness towards target cells lacking C1 but also to 
target cells lacking C2. The authors reasoned that since KIR2DL2 is sequentially 
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expressed before KIR2DL1 and they share overlapping functions, when KIR2DL2 is 
present, KIR2DL1 expression is no longer needed to the same extent [70, 149]. 
 
These results partly contradict our findings in paper II where HLA class I molecules 
have no role in selecting KIR repertoires. The reason why we could not detect such 
effects in paper II could be because we choose to group self and non-self KIRs 
together in order to get a complete picture of the impact of HLA class I. In other words, 
the effects on KIR2DL1 and KIR2DL3 imposed by HLA-C could be hidden by 
opposing effects on KIR3DL1 and KIR3DL2 by their respective ligands. Indeed, a 
thorough re-analysis of our haploA cohort revealed a tendency for preference towards 
self-KIR when studying single expression of KIR2DL1 and KIR2DL3 in C2/C2 or 
C1/C1 donors respectively (Figure 5). However, KIR3DL1 showed opposite results 
with lower expression in Bw4/Bw4 donors compared to Bw6/Bw6 donors. Notably, the 
tendency of expressing self-KIRs seems to be more apparent when focusing the 
analysis on single KIR expression rather then total KIR expression. Accordingly, we 
observe no skewing of the KIR repertoire by HLA when we considered the total KIR 
repertoire. Therefore, although our data are in line with those of Schönberg et al. with 
respect to skewing events for HLA-C binding receptors, our data clearly argue against 
an intrinsic selection event based on interactions with self-HLA class I ligands, since 





Figure 5. Frequency of self- versus nonself KIR expression for the four major inhibitory KIRs. Analysis 
focused on KIR-single positive (KIR-SP) NK cells. 
 
 
3.2.4 KIR repertoires in cord blood are not biased towards 
expression of self-receptors 
An important finding by Schönberg et al. is the observation that more naïve KIR 
repertoires in cord blood are not biased towards NK cells expressing self-HLA-C 
specific KIRs [150]. This indicates that repertoires with high expression of self-HLA C 
specific KIRs are not set during NK cell development but rather under the influence of 
environmental factors during life. The results could also explain the difference in 
outcome between studies, since cohorts may comprise of individuals with different 
exposure to pathogens that could be of major importance if intrinsic selection processes 
are not the definite cause of KIR repertoire skewing. Thus, it would be desirable to 
repeat similar high-resolution KIR repertoire assessments in a cohort large enough to 
elucidate such environmental factors. 
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3.2.5 Outlook: Skewing of KIR repertoires during viral infection 
Recently, Beziat et al. published a paper that may have implication for how we 
conceive reshaping of the NK cell receptor repertoire [151]. The authors characterized 
an expanded subset of NKG2C positive NK cells, previously demonstrated to be 
present in patients seropositive for cytomegalovirus (HCMV) [152, 153]. Interestingly, 
the thorough analysis of the NKG2C positive subset revealed that NKG2C+CD56dim 
cells preferentially expressed self-KIRs. Additionally, in contrast to the NKG2C 
negative subset that expressed KIRs in a variegated fashion, NKG2C positive cells 
were constrained to only one or two self-KIRs. Hence, the data suggested that the 
NKG2C positive subset was a result of an oligo-clonal expansion in response to viral 
infection. 
 
In light of these new findings, we speculate that randomly generated KIR repertoires 
are able to adjust during infection. The increased numbers of HLA-C specific receptors 
observed in adults, not present in cord blood, could in fact be the result of such 
repertoire skewing. When exposed to pathogens, the NK cell compartment may 
respond by undergoing a clonal expansion of the NK cell subset that is best equipped to 
handle invading pathogens. However, we believe that the KIR repertoire formed under 
steady state is not under any selection pressure and represents random expression of 
both self and non-self KIRs.  
 
 
3.3 LATE STAGE DIFFERENTIATION OF THE CD56DIM NK CELL 
POPULATION 
The mature NK cell population has traditionally been divided into two main subsets, 
the CD56bright and CD56dim NK cells [154, 155]. The CD56bright NK cells are precursors 
to the CD56dim population and the transition from bright to dim has been considered as 
the final step of differentiation [156]. Furthermore, a relative short turnover rate of two 
weeks has been observed in mature NK cells in the blood [157]. However, more recent 
studies reveal a growing complexity of the mature NK cell population, with increasing 
knowledge of receptor expression patterns, educational processes and adaptive-like 
immune responses towards virus-infected cells [152, 158, 159]. Inspired by these new 
findings we decided to explore the possibility of late stage differentiation of the NK 
population, and to investigate if further delineation of the CD56dim subset was possible. 
 
3.3.1 Late stage differentiation process 
In paper III, we observed, that during KIR acquisition, co-expression with NKG2A 
became less common, whereas co-expression with CD57 increased. We also noted that 
loss of NKG2A and acquisition of KIR and/or CD57 were all factors that were 
associated with loss of proliferative capacity to different extents. Notably, CD57 was 
associated with a near complete loss of proliferation. From this we outlined a 
differentiation model characterized by a gradual loss of NKG2A and sequential 
acquisition of KIRs and appearance CD57. There does not seem to be a single distinct 
path were cells first lose NKG2A, then gain KIR followed by CD57, but rather 
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numerous ways to achieve different stages since cells with all possible combinations of 
receptor expression are found in blood. 
 
Our model can be put in relation to other recent investigations of the CD56dim subset. 
Juelke et al. proposed a dissection of the CD56dim population, where CD62L 
expression separates cells that are able to respond to cytokine stimulation or not. 
CD62L is highly expressed on CD56bright cells as well on a subpopulation of CD56dim 
cell, and define polyfunctional cells with strong responsiveness to cytokine stimulation 
[160]. Our data show that CD62L and CD57 are usually not co-expressed, which would 
indicate that the two models could be integrated. Other proposed differentiation 
markers include the downregulation of CD94 and CD27 as well as the upregulation of 
CD6 [161-163]. CD57 has been shown to be upregulated on CD6 positive NK cells and 
on CD27 negative NK cells, which is in line with our proposed differentiation model 
[161, 164]. Possibly, all these markers of differentiation could be intertwined into a 
single unified model. 
 
3.3.2 Differentiation is associated with phenotypic and functional 
changes 
As CD57 is one of the main markers in our proposed differentiation model, we 
investigated the phenotypical and functional changes connected with its upregulation. 
These studies were mainly restricted to CD56dim NK cells, since NK cells obtained 
from cord blood or CD56bright NK cells rarely express CD57. CD56dim NK cells 
expressing CD57 showed downregulated levels of CXCR3, CXCR4 and CCR5 
chemokine receptors as well as the IL-2Rβ, and IL-18Rα cytokine receptors. Consistent 
with these findings, CD57 positive cells released less IFN-γ after cytokine stimulation 
compared to CD57 negative cells (paper III, Figure 5 and 6). Additionally, CD57 
positive cells have shown to express CD16 to a higher extent than CD57 negative cells, 
which was linked to higher production of IFN-γ and ADCC following CD16-mediated 
triggering [164, 165].  
 
To date, we have no experimental data indicating that NK cells expressing CD57 are 
exhausted. Although they respond less well to cytokine stimulation, these cells are 
important effector cells detecting target cells with downregulated self-HLA or IgG-
coated cells. Still, we do not know the main role of CD57 and why it is expressed. 
However, we propose that CD57 could be used as a marker to identify NK cells with a 
more differentiated phenotype. 
 
3.3.3 Reconstitution of NK cell receptors after transplantation 
To further strengthen the linear relationship between CD57 negative and positive NK 
cells, we set out to study expression patterns of NKG2A, KIRs and CD57 during 
immune cell reconstitution. First, we studied reconstitution of human cord blood CD34 
positive cells in BALB/c Rag2-/- γcR-/- mice. Expression of CD57 appeared after one 
week but was amplified after four weeks. In line with our previous data, CD57 positive 
NK cells did not co-express Ki67, a marker for recent proliferation. Interestingly, very 
few CD57 positive cells could be recovered from the bone marrow, thymus or lymph 
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nodes, all compartments were naïve NK cells are thought to reside. Instead, CD57 
expressing cells were located in the blood, liver and spleen, data supporting the idea 
that CD57 define more mature NK cells. In a second approach we studied NK cells 
during immune reconstitution after HSCT in humans. As shown by others, CD56bright 
NK cells and NKG2A positive CD56dim NK cells dominated the lymphocyte 
compartment the first weeks following transplantation [140, 166, 167]. Thereafter, we 
observed gradually increasing frequencies of KIR and CD57 positive NK cells, 
recapitulating those of the donors one year after transplantation. Altogether, these 
results support a model of late stage differentiation. 
 
3.3.4 Education is uncoupled from late stage differentiation 
Since we detected a correlation between KIR and CD57 expression, we wondered 
whether NK-cell education could be linked with the upregulation of CD57. However, 
CD57 expression was not coupled to education, as we saw no difference in CD57 
expression between NK cells expressing self- or nonself-KIRs. Furthermore, we 
assessed the possible association between NK cell education and the ability of NK cells 
to proliferate in response to cytokines. There was no difference in proliferative capacity 
between educated and non-educated single- or double-KIR expressing CD57 negative 
NK cells (paper III, Figure 6). At this stage, we conclude that late stage differentiation 
is linked to a loss of proliferative capacity but uncoupled from NK cell education. 
 
3.3.5 Functional calibration of the KIR repertoire with NKG2A 
In paper II we assessed the relationship between NKG2A and KIR expression by 
comparing their co-expression to calculated frequencies given by the product rule. In 
contrast to the increased observed frequencies described for KIR-KIR co-expression, 
observed frequencies of KIR-NKG2A co-expression were lower than expected by the 
product rule. Our observations are in line with previous studies were NKG2A has been 
shown to be co-expressed with KIR to a lesser extent than KIR-KIR co-expression [88, 
148]. Furthermore, our results confirmed earlier studies where NKG2A expression was 
found to be inversely correlated with KIR expression in the total population [88, 146]. 
Extending these results, we also noted that NKG2A expression was inversely correlated 
to the number of KIRs expressed on a single NK cell (paper I and III).  
 
Interestingly, we also noticed that when NKG2A was co-expressed with a KIR, it was 
more commonly expressed with a non-educated KIR than an educated KIR, suggesting 
that regulation of NKG2A expression may be linked to NK cell education (paper II, 
Figure 7B). Similar to inhibitory KIRs, NKG2A expression is associated with 
functional competence [148](paper II, III). NKG2A+KIR- cells are functional, hence 
our results supports the notion that NKG2A buffer the overall functionality of NK cells 
and we propose that NKG2A may be downregulated once the NK cell acquire 
functional competence by other means. Possibly, the interaction between a self-KIR 
and HLA ligand will initiate a series of events that provide a feedback signal for the 
downregulation of NKG2A expression. 
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3.4 KIR REPERTOIRES IN CLINICAL SETTINGS 
As discussed in the introduction (chapter 1.5.2), transplantation over HLA barriers may 
trigger NK cell alloreactivity based on missing-self recognition. Prediction of potential 
alloreactivity is based on HLA and KIR genotyping of donor and recipient, and NK cell 
alloreactivity is expected to take place when the recipient lacks one or more KIR 
ligands present in the donor [13]. However, although potential alloreactivity may be 
foreseen by HLA genotyping, the size of the potential alloreactive NK cell subset 
cannot be predicted by such methods. In an attempt to further elucidate the role of NK 
cells in transplantation settings, we set out to study the size of the alloreactive NK cell 
subset in potential donors by including an extensive phenotypical analysis of KIR 
repertoires.   
 
3.4.1 KIR3DL2-single positive cells are not educated by cognate 
ligands 
In chapter 1.3 we defined a process called education, whereby NK cells acquire 
functional competence by expressing an inhibitory KIR specific for self-HLA class I 
ligands. When the present studies were initiated, NK cell education had been shown to 
apply for three inhibitory KIRs, KIR2DL1, KIR2DL2/3 and KIR3DL1 [93, 97]. It was 
not yet known whether the inhibitory KIR3DL2 also possessed similar qualities. For 
comprehensive studies of NK cell alloreactivity in allogeneic HSCT we needed to 
obtain a complete picture of the functional donor KIR repertoires. Consequently, in 
paper I we investigated education of KIR3DL2 by its cognate ligand HLA-A3/A11. In 
contrast to other inhibitory KIRs, KIR3DL2 single positive cells were hyporesponsive 
although the corresponding ligands HLA-A3/A11 were present. Our finding 
corroborated another study published earlier the same year where hyporesponsiveness 
of KIR3DL2 positive cells was noted [148]. Why KIR3DL2 differ from the other 
inhibitory KIRs in this respect is not known, but it has been demonstrated that 
recognition of HLA-A3/A11 by KIR3DL2 is highly dependent on the presentation of 
an Epstein-Barr virus (EBV) derived peptide [72]. Although EBV is one of the most 
common viruses in humans, with around 95% latent carriers, it is possible that an active 
infection is needed to provide binding with high enough affinity to educate KIR3DL2 
positive NK cells. Another explanation of the normally hyporesponsive KIR3DL2 
positive NK cells could be that this KIR receptor has yet another function not shared 
with other inhibitory KIR receptors. Indeed, KIR3DL2 has recently been shown to 
shuttle CpG DNA down to early endosomes were CpG bind Toll-like receptor 9 
(TLR9), which indicate an antimicrobial role for KIR3DL2 expressing NK cells in 
infections [168]. Noteworthy, in paper II, we studied the co-expression of NKG2A 
and the inhibitory KIRs and it appeared that NKG2A is more frequently co-expressed 
with KIR3DL2 than other KIRs. In keeping with a buffering role of NKG2A, such co-
expression could provide functionality to uneducated KIR3DL2 expressing cells [148].  
 
3.4.2 The educated KIR repertoire 
In order to calculate the potential alloreactive NK cell subset in individuals, first we 
needed to identify the educated NK cell repertoire. In paper I, we described the 
expression pattern of four inhibitory KIR receptors, KIR2DL1, KIR2DL3, KIR3DL1 
  23 
and KIR3DL2, in 31 haploA individuals. By combining the phenotypical analysis with 
data from the HLA genotyping we could estimate the size of the educated KIR 
repertoire. We considered all NK cells that expressed at least one self-KIR to be 
educated. However, although KIR2DL1, KIR2DL3 and KIR3DL1 have all shown to 
take part in the educational process, KIR3DL2 did not possess similar qualities and was 
therefore not considered as a self-KIR in our analysis. 
 
Because many cancer types including hematological malignancies express HLA-E, we 
excluded NK cells expressing NKG2A from the pool of potentially alloreactive NK 
cells in the current analysis [169]. The resulting educated repertoire displayed great 
variation between individuals, ranging from 12 to 68% of the total CD56dim population. 
Although the lower values of this scale may appear remarkably low, they were clearly 
larger when including NKG2A, ranging from 36-97% (mean 72%).  
 
3.4.3 The size of the potential alloreactive NK cell repertoire 
For each of the 31 potential donors, we calculated the alloreactive repertoire that could 
mediate GVT effects in tentative recipients lacking one or more ligands of the donor. 
All NK cells from the donor that expressed a self-KIR where the ligand was missing in 
the recipient, and did not co-express any KIR where the ligand was present in the 
recipient, were considered to have alloreactive potential. As mentioned above, 
KIR3DL2 expression alone does not confer education. Nevertheless, KIR3DL2-
A3/A11 interaction may still inhibit the function of NK cells educated by other KIRs. 
Consequently, donor NK cells expressing KIR3DL2 were not considered to possess 
any alloreactive capacity when given to recipients harboring HLA-A3 or HLA-A11. 
 
As expected, our results show that settings with fewer KIR ligands in the recipient were 
associated with a larger size of alloreactive NK cells. Notably, among donor-recipients 
pairs that were considered mismatched by HLA genotyping, there was a striking 
difference in the size of the potential alloreactive subset ranging from 0 to 62% (paper 
I, Figure 4). Remarkably, this shows that in some situations there are no alloreactive 
NK cells even though a mismatched situation is prevailing. We argue that this may 
have implications for evaluation of clinical studies, especially when comparing 
matched- and mismatched settings. The group of mismatched donors without 
alloreactive NK cells could perhaps account for some of the differences between 
studies. 
 
To date there are many confounding parameters that may vary between transplantation 
procedures, which makes it difficult to evaluate the possible beneficial effect of NK 
cells in HSCTs. Here we show that donors who are mismatched at the genetic level 
display variable frequencies of possible alloreactive NK cells. Thus, we propose that in 
order to analyze the impact of alloreactive NK cells in transplantation settings more 
accurately, it would be beneficial if phenotypical analysis of the KIR repertoire were 
included in such procedures. 
 
It is important to note, that the estimation of the size of the educated and alloreactive 
subset was calculated theoretically based on values given by the phenotypical analysis 
of the KIR repertoire in healthy individuals and was not based on any functional 
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experiments. As demonstrated by De Santis et al., functional competence of NK cells 
correlates well with the predicted alloreactive subsets. However, exceptions were also 
found in potential donors were NK cell reactivity was less then expected [170]. 
 
In allogeneic stem cell transplantation it is seldom possible to chose between different 
donors. However, in settings of allogeneic NK cell therapy with haploidentical donors, 
a donor selection strategy may be developed based on a combination of geno- and 
phenotyping 
 
3.4.4 Re-education of NK cells in transplantation settings 
An additional factor to consider when transplanting over HLA barriers is the possibility 
of re-education of NK cells. Joncker et al. and Elliot et al. demonstrated in 2010 that 
mouse NK cells could be reprogrammed after being exposed to a new MHC 
environment [106, 107]. In their experiments, NK cells from MHC class I sufficient 
mice were adoptively transfer into MHC class I deficient mice. Surprisingly, instead of 
showing hyperactive killing capacity, the cells became anergic after a few days. In a 
complementary experiment, NK cells from MHC class I deficient mice were adoptively 
transferred into MHC class I sufficient mice. The previously anergic NK cells showed 
high levels of IFN-γ production and degranulated when stimulated by activating 
receptors.  
 
These data suggest that education is not a static condition but is changeable over time, 
even in mature NK cells. This theory is supported by findings published by Brodin et 
al., where the authors formulate the “Rheostat model” based on the observation that 
mouse NK cells can tune their responsiveness depending on the continuous interactions 
between inhibitory Ly49 and MHC class I alleles (see chapter 1.3.2 and [108]). Such 
tuning events may make calculations of alloreactive cells in the donor less meaningful. 
If re-education takes place after cells been transferred, then the estimated frequency of 
alloreactive cells may be misleading. However, so far re-education has only been 
demonstrated in mice and might not hold true in humans. Haas et al. studied NK cell 
education after HSCTs in humans, and found that donor HLA determines the educated 
subset. The responsiveness of the NK cell repertoire was monitored for at least three 
years after transplantation date, and showed no signs of being re-educated [171]. An 
essential difference between the studies conducted in mice and humans was the source 
of NK cells. In the murine setting, pure NK cells were transferred into the new host. In 
contrast, human individuals were given CD34+ stem cells, which will differentiate into 
a number of different cell types. Hence, other donor-derived hematopoietic cells may 
provide the HLA environment needed for NK cell education. 
 
In conclusion, the role of NK cells in transplantation settings is still elusive, and we 
need to refine the immunomonitoring of transplantation procedures to better dissect the 
possible beneficial effect that NK cells may exercise. We propose that one such step 
could be to include a phenotypical evaluation of the donor KIR repertoire. 
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3.4.5 Skewing of the KIR repertoire by hypomethylating agents 
As mentioned before, studies indicate that KIR expression is regulated at the 
transcriptional level by epigenetic changes (see chapter 1.2.4). CpG islands surrounding 
the transcriptional start site are the primary targets for methylation, which subsequently 
determine the transcription of the gene. KIR genes are consistently demethylated in 
cells expressing KIRs and methylated in cells without KIR expression [82, 84].  
 
The fact that expression of KIR genes correlate with the methylation status of the 
promoter raises the possibility that KIR expression may be altered in the presence of 
hypo- or hypermethylating agents. Indeed, Santourlidis et al. have in vitro shown that a 
hypomethylating drug labeled 5-aza-2’-deoxycytidine may possess such qualities [84]. 
5-azacytidine and its deoxy derivative 5-aza-2’-deoxycytidine have been approved for 
the treatment of human cancer, and are commonly used by patients diagnosed with 
high-risk myelodysplastic syndromes (MDS) [172]. However, although the treatment 
appears to be effective, the underlying mechanisms are still unknown.  
 
Since little was known about 5-azacytidines effects in vivo, we wanted to investigate 
whether 5-azacytidine alter KIR expression of NK cells in MDS patients undergoing 
treatment with this drug.  
 
3.4.5.1 Presence of 5-azacytidine during cell division increases KIR expression in 
vitro 
We began by establishing a robust staining panel that could be applicable on our MDS 
samples. The KIR panel was designed by testing it on NK cells isolated from blood 
from healthy donors and subsequently stimulated with 5-azacytidine in vitro. 
Surprisingly, we saw no difference in KIR expression between treated and non-treated 
NK cells. However, after including a cell division marker, carboxyfluorescein diacetate 
succinimidyl ester (CFSE), we observed that only cells that had undergone more than 
three cell divisions had upregulated levels of KIRs (Figure 6). These cells were not 
detectable when looking at the total NK cell repertoire, because they were outnumbered 
by the more frequent subset of undivided cells. Hence, incorporation of 5-azacytidine 
into the DNA during cell division is necessary for modification of KIR expression to be 
seen on the protein level. 
 
3.4.5.2 Patients treated with 5-azacytidine show stable KIR repertoires in blood 
Next, we set out to investigate KIR expression in MDS patients treated with 5-
azacytidine. Patients were administered 5-azacytidine in cycles, one dose of 5-
azacytidine for five consecutive days followed by three weeks of rest. Blood samples 
were collected before and during treatment, at day one and five of cycle one, four and 
ten. Unexpectedly, expression of KIRs was very stable during treatment, even ten 
months into therapy (unpublished data). Since our previous studies had shown cell 
proliferation to be a vital step, we included Ki67, a marker used in flow cytometry to 
identify cells that have undergone proliferation. However, even when focusing our 
analysis on Ki67 positive NK cells, no skewing of the KIR repertoire was detected. 
This led us to question whether 5-azacytidine had any hypomethylating effect in 
lymphocytes in the blood. Strikingly, when measuring the overall methylation of 
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peripheral blood mononuclear cells in the blood collected from patients, we observed 




Figure 6. KIR expression on NK cells having undergone cell division in the absence (white bars) or 
presence (black bars) of 5-azacytidine. Mean values and  standard deviation are shown. n=10. 
 
 
At this stage, we can conclude that KIR expression patterns are stable in patients 
receiving 5-azacytidine treatment. The skewing of KIR repertoires seen in in vitro 
studies does not relate to what is occurring in the physiological setting in patients. The 
fact that the overall methylation status is constant in patients suggests that 5-azacytidine 
treatment does not affect NK cells in the blood. We can only speculate that factors such 
as drug dosage and NK cell proliferation could be of great importance in identifying the 
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4 CONCLUDING REMARKS 
Data presented in this thesis describes the formation of the KIR repertoire in human 
NK cells. We show that highly variable KIR repertoires fulfill the criteria necessary for 
broad target cell specificity and self tolerance without the need for any selection 
process imposed by self HLA class I ligands. Furthermore, this thesis underlines the 
potential risk to over estimate NK cell alloreactivity in mismatched transplantation 
settings when predicted alloreactivity is only based on HLA genotype. Finally, our data 
also indicate that the CD56dim phenotype does not define the final step of NK cell 
development. Instead, the CD56dim population can be further divided into smaller 
subsets representing different stages of a late stage differentiation process. The main 
findings are summarized below. 
 
• KIR3DL2 single positive cells are not educated by HLA-A3/A11 (paper I) 
• The size of the estimated alloreactive NK cell repertoire is highly variable 
among tentative mismatched donors (paper I) 
• KIR acquisition probabilities increase with cellular KIR expression (paper II) 
• HLA class I molecules do not influence the formation of the KIR repertoire on a 
population level (paper II) 
• NKG2A expression is inversely correlated with the number of co-expressed 
KIRs, and is more frequent on noneducated than educated NK cells (paper I, II 
and III) 
• Gradual loss of NKG2A, sequential acquisition of KIRs and the appearance 
CD57 characterize different steps of late stage differentiation in the CD56dim 
NK cell population (paper III) 
• CD56dim differentiation and NK cell education are parallel, but uncoupled, 
processes (paper III)  
 
In addition to the above findings, a lot of work has been put on refining flow cytometry 
protocols. Particularly, developing multicolor staining panels that allow detailed 
phenotypical characterization of human NK cells. 
 
In conclusion, I would like to emphasize the importance of correlating genotypic data 
with phenotypical analyses. The great variability in human KIR repertoires may have 
an impact on how individuals are able to cope with viral infections, cancers and other 
diseases. Until we fully understand the probabilistic switch of the KIR proximal 
promoter, which regulates transcription of KIR genes, we should consider including 
measurements of KIR protein expression in future disease association studies. As 
demonstrated in paper I, the estimated size of alloreactive NK cells in potential donors 
of HSCTs was based on KIR frequencies. Possibly, such calculations could be useful in 
the evaluation of other treatment settings, to help define which subset of the NK cell 
population that is responsible for the proposed effects on disease outcome. 
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